Status Unknown

Age: 18Years - 75Years
All Genders
ID05439577

A Multicentre, Prospective and Registry Study to Explore the Efficacy and Safety of Mucopolysaccharide Polysulfate Cream in the Treatment of Patients With Eczema

Led by Shenzhen Kangzhe Pharmaceutical Co., Ltd. · Updated on 2022-06-30

1800

Participants Needed

1

Research Sites

8 weeks

Total Duration

On this page

Sponsors

S

Shenzhen Kangzhe Pharmaceutical Co., Ltd.

Lead Sponsor

B

Beijing Friendship Hospital

Collaborating Sponsor

AI-Summary

What this Trial Is About

The study was designed to collect information over 1800 patients with a clinical diagnosis of subacute or chronic eczema, these patients' prescriptions contain Hirudoid®. EASI, IGA and more indicators are evaluated. Data were collected for a maximum of 12 weeks according to the clinician's consultation and follow-up (Time points were set at baseline, 1, 2, 3, 4, 8 and 12 weekends). The above data were analysed to explore the optimal treatment modality, dose and treatment period for patients with subacute or chronic eczema.

CONDITIONS

Official Title

A Multicentre Study to Explore the Efficacy and Safety of Mucopolysaccharide Polysulfate Cream in Patients With Eczema

Who Can Participate

Age: 18Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  1. 18-75 years of age, male or female;.
  2. Patients with a clinical diagnosis of subacute or chronic eczema and whose prescription contains Hirudoid®.
  3. Subjects fully understand the content of this study, sign informed consent.
Not Eligible

You will not qualify if you...

  1. Hypersensitivity to any of the ingredients of this product.
  2. Patients with heparin hypersensitivity, bleeding-prone constitution and known heparin-induced thrombocytopenia.
  3. Open wounds and broken skin and mucous membranes
  4. Patients with localized combined bacterial, viral and fungal infections.
  5. Pregnant or lactating women or those who are unable to use contraception during the study period
  6. Those with psychiatric disorders, poor compliance and unable to complete the study.
  7. Any other reason that the investigator considers inappropriate for inclusion.

Trial Site Locations

Total: 1 location

1

Beijing Friendship Hospital, Capital Medical University

Beijing, Beijing Municipality, China, 100050

Actively Recruiting

Loading map...

Research Team

L

Lingfeng Li

Y

Yue Li

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here